Finance

ROSEN Law Firm Urges OCGN Investors to Act Prior to Legal Deadline in Securities Class Action

Published May 7, 2024

Investor Reminder: Ocugen, Inc. Securities Class Action Imminent Deadline

NEW YORK, May 07, 2024 -- The esteemed Rosen Law Firm is issuing a final call to investors holding shares of Ocugen, Inc. OCGN, a company specialized in innovative therapies for blindness, to enlist legal counsel before an important approaching deadline in a securities class action that the firm originally filed. This alert emphasizes the importance for shareholders of Ocugen, Inc., whose operations are based in Malvern, Pennsylvania, to act swiftly in order to participate in the legal proceedings.

Legal Representation Encouraged for OCGN Investors

The global investor rights law firm, Rosen, underscores its commitment to representing investors worldwide who have been victims of securities frauds. The firm's extensive experience in handling class action lawsuits places it as a trusted counsel for investors seeking to secure their rights. Ocugen, Inc. investors are reminded to seek legal guidance before the impending deadline to ensure their interests are duly represented in the class action suit against the company.

Investors are urged not to miss the deadline to join the class action lawsuit that accuses Ocugen, Inc. of financial improprieties tied to its business dealings, which have potentially led to significant shareholder losses. The firm reasserts the urgency for investors to come forward to preserve their rights in this time-sensitive matter.

Rosen, Ocugen, Deadline